Evidence for pain modulation by pre- and postsynaptic noradrenergic receptors in the medulla oblongata

Jacqueline Sagen, Herbert K. Proudfit

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Activation of neurons in nucleus raphe magnus (NRM) produces hypoalgesia which most likely results from inhibition of spinal cord pain transmission pathways. Previous reports from this laboratory suggest that noradrenergic (NA) neurons modulate the activity of NRM neurons. More specifically, NA projections to NRM neurons appear to be inhibitory since iontophoretically applied norepinephrine (NE) inhibits the activity of NRM neurons. Furthermore, blockade of NA receptors in the NRM by the microinjection of alpha-adrenergic antagonists produces potent analgesia. Thus, the NA input to the NRM appears to increase pain sensitivity by tonically inhibiting NRM neurons. Pharmacological and physiological studies have differentiated alpha-adrenergic receptors into alpha-1 and alpha-2 subtypes. The present study was designed to examine the nature of the alpha-adrenergic receptor subtypes in the NRM and their role in the modulation of pain sensitivity. The results of these experiments are consistent with the classical model of postsynaptic alpha-1 receptors and presynaptic alpha-2 receptors which modulate NE release. Both the alpha-1 antagonist, prazosin, and the alpha-2 agonist, clonidine, produced an increase in nociceptive threshold. Conversely, both the alpha-1 agonist, phenylephrine, and the alpha-2 antagonist, yohimbine, produced a decrease in nociceptive threshold. Thus, in the region of the NRM, both presynaptic alpha-2 and postsynaptic alpha-1 noradrenergic receptors may be involved in the modulation of nociception.

Original languageEnglish
Pages (from-to)285-293
Number of pages9
JournalBrain Research
Volume331
Issue number2
DOIs
StatePublished - Apr 8 1985
Externally publishedYes

Fingerprint

Medulla Oblongata
Pain
Neurons
Receptors, Adrenergic, alpha
Norepinephrine
Adrenergic alpha-Antagonists
Presynaptic Receptors
Nucleus Raphe Magnus
Adrenergic Neurons
Nociception
Yohimbine
Prazosin
Clonidine
Microinjections
Phenylephrine
Analgesia
Spinal Cord
Pharmacology

Keywords

  • agonists
  • analgesia
  • antagonists
  • brainstem
  • noradrenergic
  • nucleus raphe magnus
  • pain

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Evidence for pain modulation by pre- and postsynaptic noradrenergic receptors in the medulla oblongata. / Sagen, Jacqueline; Proudfit, Herbert K.

In: Brain Research, Vol. 331, No. 2, 08.04.1985, p. 285-293.

Research output: Contribution to journalArticle

@article{45bdc3d1e87c44fdb0eb959fd39fa84a,
title = "Evidence for pain modulation by pre- and postsynaptic noradrenergic receptors in the medulla oblongata",
abstract = "Activation of neurons in nucleus raphe magnus (NRM) produces hypoalgesia which most likely results from inhibition of spinal cord pain transmission pathways. Previous reports from this laboratory suggest that noradrenergic (NA) neurons modulate the activity of NRM neurons. More specifically, NA projections to NRM neurons appear to be inhibitory since iontophoretically applied norepinephrine (NE) inhibits the activity of NRM neurons. Furthermore, blockade of NA receptors in the NRM by the microinjection of alpha-adrenergic antagonists produces potent analgesia. Thus, the NA input to the NRM appears to increase pain sensitivity by tonically inhibiting NRM neurons. Pharmacological and physiological studies have differentiated alpha-adrenergic receptors into alpha-1 and alpha-2 subtypes. The present study was designed to examine the nature of the alpha-adrenergic receptor subtypes in the NRM and their role in the modulation of pain sensitivity. The results of these experiments are consistent with the classical model of postsynaptic alpha-1 receptors and presynaptic alpha-2 receptors which modulate NE release. Both the alpha-1 antagonist, prazosin, and the alpha-2 agonist, clonidine, produced an increase in nociceptive threshold. Conversely, both the alpha-1 agonist, phenylephrine, and the alpha-2 antagonist, yohimbine, produced a decrease in nociceptive threshold. Thus, in the region of the NRM, both presynaptic alpha-2 and postsynaptic alpha-1 noradrenergic receptors may be involved in the modulation of nociception.",
keywords = "agonists, analgesia, antagonists, brainstem, noradrenergic, nucleus raphe magnus, pain",
author = "Jacqueline Sagen and Proudfit, {Herbert K.}",
year = "1985",
month = "4",
day = "8",
doi = "10.1016/0006-8993(85)91554-9",
language = "English",
volume = "331",
pages = "285--293",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Evidence for pain modulation by pre- and postsynaptic noradrenergic receptors in the medulla oblongata

AU - Sagen, Jacqueline

AU - Proudfit, Herbert K.

PY - 1985/4/8

Y1 - 1985/4/8

N2 - Activation of neurons in nucleus raphe magnus (NRM) produces hypoalgesia which most likely results from inhibition of spinal cord pain transmission pathways. Previous reports from this laboratory suggest that noradrenergic (NA) neurons modulate the activity of NRM neurons. More specifically, NA projections to NRM neurons appear to be inhibitory since iontophoretically applied norepinephrine (NE) inhibits the activity of NRM neurons. Furthermore, blockade of NA receptors in the NRM by the microinjection of alpha-adrenergic antagonists produces potent analgesia. Thus, the NA input to the NRM appears to increase pain sensitivity by tonically inhibiting NRM neurons. Pharmacological and physiological studies have differentiated alpha-adrenergic receptors into alpha-1 and alpha-2 subtypes. The present study was designed to examine the nature of the alpha-adrenergic receptor subtypes in the NRM and their role in the modulation of pain sensitivity. The results of these experiments are consistent with the classical model of postsynaptic alpha-1 receptors and presynaptic alpha-2 receptors which modulate NE release. Both the alpha-1 antagonist, prazosin, and the alpha-2 agonist, clonidine, produced an increase in nociceptive threshold. Conversely, both the alpha-1 agonist, phenylephrine, and the alpha-2 antagonist, yohimbine, produced a decrease in nociceptive threshold. Thus, in the region of the NRM, both presynaptic alpha-2 and postsynaptic alpha-1 noradrenergic receptors may be involved in the modulation of nociception.

AB - Activation of neurons in nucleus raphe magnus (NRM) produces hypoalgesia which most likely results from inhibition of spinal cord pain transmission pathways. Previous reports from this laboratory suggest that noradrenergic (NA) neurons modulate the activity of NRM neurons. More specifically, NA projections to NRM neurons appear to be inhibitory since iontophoretically applied norepinephrine (NE) inhibits the activity of NRM neurons. Furthermore, blockade of NA receptors in the NRM by the microinjection of alpha-adrenergic antagonists produces potent analgesia. Thus, the NA input to the NRM appears to increase pain sensitivity by tonically inhibiting NRM neurons. Pharmacological and physiological studies have differentiated alpha-adrenergic receptors into alpha-1 and alpha-2 subtypes. The present study was designed to examine the nature of the alpha-adrenergic receptor subtypes in the NRM and their role in the modulation of pain sensitivity. The results of these experiments are consistent with the classical model of postsynaptic alpha-1 receptors and presynaptic alpha-2 receptors which modulate NE release. Both the alpha-1 antagonist, prazosin, and the alpha-2 agonist, clonidine, produced an increase in nociceptive threshold. Conversely, both the alpha-1 agonist, phenylephrine, and the alpha-2 antagonist, yohimbine, produced a decrease in nociceptive threshold. Thus, in the region of the NRM, both presynaptic alpha-2 and postsynaptic alpha-1 noradrenergic receptors may be involved in the modulation of nociception.

KW - agonists

KW - analgesia

KW - antagonists

KW - brainstem

KW - noradrenergic

KW - nucleus raphe magnus

KW - pain

UR - http://www.scopus.com/inward/record.url?scp=0022002623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022002623&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(85)91554-9

DO - 10.1016/0006-8993(85)91554-9

M3 - Article

VL - 331

SP - 285

EP - 293

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -